Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 164

Results For "products"

2018 News Found

Comar expands packaging solutions with Omega acquisition
Packaging | December 30, 2021

Comar expands packaging solutions with Omega acquisition

The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise


Merck awarded €121 million contract for flow membrane production facility in Wisconsin, USA
Diagnostic Center | December 30, 2021

Merck awarded €121 million contract for flow membrane production facility in Wisconsin, USA

The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness


VivaLyf Innovations to launch EzLyf, India's first non-invasive glucometer
Startup | December 30, 2021

VivaLyf Innovations to launch EzLyf, India's first non-invasive glucometer

The glucometer connects to one’s smartphone and provides actionable diagnostic information


Sanofi loses appeal in the US over Lantus device patents
News | December 30, 2021

Sanofi loses appeal in the US over Lantus device patents

Decisions reaffirm the ability of Biocon Biologics and Viatris to provide patient access to interchangeable Semglee


G42 Healthcare, Abu Dhabi and AstraZeneca to collaborate on clinical research
Biotech | December 29, 2021

G42 Healthcare, Abu Dhabi and AstraZeneca to collaborate on clinical research

G42 Healthcare and AstraZeneca will work closely together to explore real-world evidence and conduct clinical trials through IROS – the first-of-its-kind Contract Research Organization (CRO) in the UAE


Trastuzumab deruxtecan type II variation application validated by EMA
Biotech | December 28, 2021

Trastuzumab deruxtecan type II variation application validated by EMA

Application based on DESTINY-Breast03 results showing Daiichi Sankyo and AstraZeneca’s trastuzumab deruxtecan reduced risk of disease progression or death by 72% versus trastuzumab emtansine (T-DM1)


Cipla receives EUA for Cipmolnu
Drug Approval | December 28, 2021

Cipla receives EUA for Cipmolnu

The Subject Expert Committee (SEC), on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) on Monday recommended granting permission to manufacture and market anti-Covid pill molnupiravir for restricted emergency use


Sun Pharma receives DCGI approval for Molxvir in India
Drug Approval | December 28, 2021

Sun Pharma receives DCGI approval for Molxvir in India

The product is expected to be available in a week’s time


India’s 1st indigenously developed protein sub-unit Covid-19 vaccine Corbevax gets nod
Drug Approval | December 28, 2021

India’s 1st indigenously developed protein sub-unit Covid-19 vaccine Corbevax gets nod

It plans to deliver over 300 million doses to the Indian government


Torrent Pharma to launch molnupiravir under the brand name Molnutor in India
Drug Approval | December 28, 2021

Torrent Pharma to launch molnupiravir under the brand name Molnutor in India

DCGI approved the drug based on the review of clinical data